LCN2 is another hopeful marker that nearly perfectly discriminates between controls and confirmed infections in a small cohort of patients (72 patients/22 PJI) (Figures 2, 3) (Vergara et al., 2019). The gene discussed is LCN2; the disease is juvenile polyposis syndrome.